H-VIOS
DEAD

Serial Number

97579117

Owner

3D SYSTEMS INC.

Attorney

Brian M. Davis

Filing Date

Sep 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

H-VIOS Trademark

Serial Number: 97579117

H-VIOS is a trademark filed by 3D SYSTEMS INC. on September 6, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

3D SYSTEMS INC. (197 trademarks)

333 THREE D SYSTEMS CIRCLE
ROCK HILL, SC 29730

Entity Type: 03

Trademark Details

Filing Date

September 6, 2022

Registration Date

Not Registered

Published for Opposition

September 26, 2023

Goods & Services

Bioreactors for cell culturing; cell culture apparatus for laboratory use, namely, cell culture instrument using tissue cultures in a microfluidic device; laboratory apparatus, namely, systems comprised of bioreactors for laboratory use and cell assembly apparatus for laboratory use for fabrication of three dimensional (3D) engineered living tissues; downloadable computer software for programming and executing statistical analysis of data sets and for data analysis

Three dimensional printing (3DP) services for other; 3D Bioprinting, namely, fabrication of living tissue models using specialized three dimensional printers; Bioprinting, namely, fabrication of living tissue models; creation of customized three-dimensional shaped parts using rapid prototyping equipment

Biologically compatible polymers, namely, resins or hydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; cells for scientific, laboratory or medical research; diagnostic preparations for scientific or research use

Cell culture apparatus for medical use, namely, cell culture instrument using tissue cultures in a microfluidic device

Scientific research and development in the fields of drug discovery and pharmaceutical drug development; industrial research in the field of drug discovery and development; pharmaceutical research and development services; providing medical research and scientific research information in the field of medicine and pharmaceuticals; providing temporary use of online, non-downloadable computer software for programming and executing statistical analysis of data sets and for data analysis; cell culture services for scientific and research purposes, for others

Biological tissue cultures for medical purposes; diagnostic preparations for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 22, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 22, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2025 EXRA
SOU EXTENSION 3 GRANTED
May 15, 2025 EX3G
SOU EXTENSION 3 FILED
May 15, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
May 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2024 EXRA
SOU EXTENSION 2 GRANTED
Nov 14, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 14, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 18, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 17, 2024 EX1G
SOU EXTENSION 1 FILED
May 17, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 17, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 18, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 18, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 18, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 18, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 18, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 21, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2022 NWOS
NEW APPLICATION ENTERED
Sep 9, 2022 NWAP